Liver decompensation in HIV/Hepatitis B coinfection in the cART era does not seem increased compared to hepatitis B mono ‐infection

ConclusionsHIV/HBV coinfected patients no longer seem to be at increased risk for progression to ESLD compared to HBV mono ‐infected patients, likely due to widespread use of highly effective cART with dual HBV and HIV activity.This article is protected by copyright. All rights reserved.

Source: Liver International - November 9, 2018 Category: Gastroenterology Authors: Faydra I. Lieveld, Colette Smit, Clemens Richter, Karel J. van Erpecum, Bernhard W.M. Spanier, Elisabeth H. Gisolf, Jan M. Vrolijk, Peter D. Siersema, Andy I.M. Hoepelman, Peter Reiss, Joop E. Arends Tags: Original Article Source Type: research